The FDA has revoked their approval of the medication Avastin for the treatment of breast cancer. According to the FDA, there’s no proof that the drug extends the lives of breast cancer victims and there could be major side effects. The FDA’s ruling on Friday came as no surprise, but it was still a disappointment to women and breast cancer advocates. Read more after the jump. Julie1205